Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 31

1.

A roadmap for strengthening evidence-informed health policy-making in Iran: protocol for a research programme.

Sajadi HS, Majdzadeh R, Yazdizadeh B, Mohtasham F, Mohseni M, Doshmangir L, Lavis J.

Health Res Policy Syst. 2019 May 17;17(1):50. doi: 10.1186/s12961-019-0455-9.

2.

Setting research priorities to achieve long-term health targets in Iran.

Mansoori P, Majdzadeh R, Abdi Z, Rudan I, Chan KY; Iranian CHNRI Health Research Priority Setting Group, Aarabi M, Ahmadnezhad E, Ahmadnia S, Akhondzadeh S, Azin A, Azizi F, Dehnavieh R, Eini-Zinab H, Farzadfar F, Farzaei MH, Ghanei M, Haghdoost A, Hantoushzadeh S, Heydari G, Joulaei H, Kalantari N, Kelishadi R, Khosravi A, Larijani B, Mahvi AH, Bavani ARM, Mesdaghinia A, Mokri A, Montazeri A, Mostafavi E, Motevalian SA, Naddafi K, Nikfar S, Nojoumi SA, Noroozian M, Olyaeemanesh A, Omidvar N, Ostadtaghizadeh A, Pourmalek F, Rahimi R, Rahimi-Movaghar A, Rashidian A, Razaghi E, Sadeghi-Bazargani H, Zalani GS, Soori H, Tabrizi JS, Vedadhir A, Yazdizadeh B, Yunesian M, Zare M.

J Glob Health. 2018 Dec;8(2):020702. doi: 10.7189/jogh.08.020702.

3.

Correction to: Impact assessment of Iran's health technology assessment programme.

Yazdizadeh B, Mohtasham F, Velayati A.

Health Res Policy Syst. 2018 Sep 7;16(1):89. doi: 10.1186/s12961-018-0369-y.

4.

Assessment of research systems in universal health coverage-related organizations.

Yazdizadeh B, Mohtasham F.

Med J Islam Repub Iran. 2018 Feb 25;32:15. doi: 10.18869/mjiri.32.15. eCollection 2018.

5.

Choosing Appropriate Theories for Understanding Hospital Reporting of Adverse Drug Events, a Theoretical Domains Framework Approach.

Shalviri G, Yazdizadeh B, Mirbaha F, Gholami K, Majdzadeh R.

Iran J Pharm Res. 2018 Spring;17(2):811-821.

6.

Impact assessment of Iran's health technology assessment programme.

Yazdizadeh B, Mohtasham F, Velayati A.

Health Res Policy Syst. 2018 Feb 22;16(1):15. doi: 10.1186/s12961-018-0286-0. Erratum in: Health Res Policy Syst. 2018 Sep 7;16(1):89.

7.

Newborn screening for galactosaemia.

Lak R, Yazdizadeh B, Davari M, Nouhi M, Kelishadi R.

Cochrane Database Syst Rev. 2017 Dec 23;12:CD012272. doi: 10.1002/14651858.CD012272.pub2. Review.

8.

A Qualitative Assessment of the Evidence Utilization for Health Policy-Making on the Basis of SUPPORT Tools in a Developing Country.

Hasan Imani-Nasab M, Seyedin H, Yazdizadeh B, Majdzadeh R.

Int J Health Policy Manag. 2017 Jan 8;6(8):457-465. doi: 10.15171/ijhpm.2016.158.

9.

Impact of Health Research Systems on Under-5 Mortality Rate: A Trend Analysis.

Yazdizadeh B, Parsaeian M, Majdzadeh R, Nikooee S.

Int J Health Policy Manag. 2016 Nov 26;6(7):395-402. doi: 10.15171/ijhpm.2016.147.

10.

Validity and reliability of the Evidence Utilisation in Policymaking Measurement Tool (EUPMT).

Imani-Nasab MH, Yazdizadeh B, Salehi M, Seyedin H, Majdzadeh R.

Health Res Policy Syst. 2017 Aug 4;15(1):66. doi: 10.1186/s12961-017-0232-6.

11.

Iran Diabetes Research Roadmap (IDRR): the study protocol.

Shafiee G, Nasli-Esfahani E, Bandarian F, Peimani M, Yazdizadeh B, Razi F, Farzadfar F, Larijani B.

J Diabetes Metab Disord. 2016 Dec 15;15:58. doi: 10.1186/s40200-016-0277-z. eCollection 2016.

12.

STAKEHOLDER INVOLVEMENT IN HEALTH TECHNOLOGY ASSESSMENT AT NATIONAL LEVEL: A STUDY FROM IRAN.

Yazdizadeh B, Shahmoradi S, Majdzadeh R, Doaee S, Bazyar M, Souresrafil A, Olyaeemanesh A.

Int J Technol Assess Health Care. 2016 Jan;32(3):181-9. doi: 10.1017/S0266462316000167. Epub 2016 Aug 15.

PMID:
27524462
13.

An assessment of health research impact in Iran.

Yazdizadeh B, Majdzadeh R, Janani L, Mohtasham F, Nikooee S, Mousavi A, Najafi F, Atabakzadeh M, Bazrafshan A, Zare M, Karami M.

Health Res Policy Syst. 2016 Jul 26;14(1):56. doi: 10.1186/s12961-016-0129-9.

14.

Health technology assessment in Iran: Barriers and solutions.

Mohtasham F, Yazdizadeh B, Zali Z, Majdzadeh R, Nedjat S.

Med J Islam Repub Iran. 2016 Jan 26;30:321. eCollection 2016.

15.

Perceived barriers to reporting adverse drug events in hospitals: a qualitative study using theoretical domains framework approach.

Mirbaha F, Shalviri G, Yazdizadeh B, Gholami K, Majdzadeh R.

Implement Sci. 2015 Aug 7;10:110. doi: 10.1186/s13012-015-0302-5.

16.

Research's Practice and Barriers of Knowledge Translation in Iran.

Nedjat S, Gholami J, Yazdizadeh B, Nedjat S, Maleki K, Majdzadeh R.

Iran J Public Health. 2014 Jul;43(7):968-80.

17.

How can we establish more successful knowledge networks in developing countries? Lessons learnt from knowledge networks in Iran.

Yazdizadeh B, Majdzadeh R, Alami A, Amrolalaei S.

Health Res Policy Syst. 2014 Oct 29;12:63. doi: 10.1186/1478-4505-12-63.

18.

Application of Capture-Recapture for Fine-tuning Uncertainties About National Maternal Mortality Estimates.

Yazdizadeh B, Mohammad K, Nedjat S, Changizi N, Azemikhah A, Jafari N, Radpoyan L, Majdzadeh R.

Int J Prev Med. 2014 May;5(5):624-31.

19.

Development of evidence-based health policy documents in developing countries: a case of Iran.

Imani-Nasab MH, Seyedin H, Majdzadeh R, Yazdizadeh B, Salehi M.

Glob J Health Sci. 2014 Feb 7;6(3):27-36. doi: 10.5539/gjhs.v6n3p27.

20.

Health science and technology evaluation: emerging for innovation.

Yazdizadeh B.

Int J Prev Med. 2013 Sep;4(9):985-7. No abstract available.

Supplemental Content

Loading ...
Support Center